Literature DB >> 9192672

Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map.

N Zhao1, A Stoffel, P W Wang, J D Eisenbart, R Espinosa, R A Larson, M M Le Beau.   

Abstract

Loss of a whole chromosome 5 or a deletion of the long arm, del(5q), is a recurring abnormality in malignant myeloid diseases. In previous studies, we delineated a commonly deleted segment of approximately 4 Mb within band 5q31 that was flanked by IL9 on the proximal side and D5S166 on the distal side. We have generated a physical map of P1 (PAC), bacterial (BAC), and yeast artificial chromosome (YAC) clones of this interval. The contig consists of 108 clones (78 PACs, 2 BACs, and 28 YACs) to which 125 markers (5 genes, 11 expressed sequence tags, 12 polymorphisms, and 97 sequence-tagged sites) have been mapped. Using PAC clones for fluorescence in situ hybridization analysis of leukemia cells with a del(5q), we have narrowed the commonly deleted segment to 1-1.5 Mb between D5S479 and D5S500. To search for allele loss, we used 7 microsatellite markers within and flanking the commonly deleted segment to examine leukemia cells from 28 patients with loss of 5q, and 14 patients without cytogenetically detectable loss of 5q. In the first group of patients, we detected hemizygous deletions, consistent with the cytogenetically visible loss; no homozygous deletions were detected. No allele loss was detected in patients without abnormalities of chromosome 5, suggesting that allele loss on 5q is the result of visible chromosomal abnormalities. The development of a stable PAC contig and the identification of the smallest commonly deleted segment will facilitate the molecular cloning of a myeloid leukemia suppressor gene on 5q.

Entities:  

Mesh:

Year:  1997        PMID: 9192672      PMCID: PMC21265          DOI: 10.1073/pnas.94.13.6948

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Fluorescence in situ hybridization of YAC clones after Alu-PCR amplification.

Authors:  C Lengauer; E D Green; T Cremer
Journal:  Genomics       Date:  1992-07       Impact factor: 5.736

2.  The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage.

Authors:  H Q Nguyen; B Hoffman-Liebermann; D A Liebermann
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

Review 3.  A gene map of the human genome.

Authors:  G D Schuler; M S Boguski; E A Stewart; L D Stein; G Gyapay; K Rice; R E White; P Rodriguez-Tomé; A Aggarwal; E Bajorek; S Bentolila; B B Birren; A Butler; A B Castle; N Chiannilkulchai; A Chu; C Clee; S Cowles; P J Day; T Dibling; N Drouot; I Dunham; S Duprat; C East; C Edwards; J B Fan; N Fang; C Fizames; C Garrett; L Green; D Hadley; M Harris; P Harrison; S Brady; A Hicks; E Holloway; L Hui; S Hussain; C Louis-Dit-Sully; J Ma; A MacGilvery; C Mader; A Maratukulam; T C Matise; K B McKusick; J Morissette; A Mungall; D Muselet; H C Nusbaum; D C Page; A Peck; S Perkins; M Piercy; F Qin; J Quackenbush; S Ranby; T Reif; S Rozen; C Sanders; X She; J Silva; D K Slonim; C Soderlund; W L Sun; P Tabar; T Thangarajah; N Vega-Czarny; D Vollrath; S Voyticky; T Wilmer; X Wu; M D Adams; C Auffray; N A Walter; R Brandon; A Dehejia; P N Goodfellow; R Houlgatte; J R Hudson; S E Ide; K R Iorio; W Y Lee; N Seki; T Nagase; K Ishikawa; N Nomura; C Phillips; M H Polymeropoulos; M Sandusky; K Schmitt; R Berry; K Swanson; R Torres; J C Venter; J M Sikela; J S Beckmann; J Weissenbach; R M Myers; D R Cox; M R James; D Bentley; P Deloukas; E S Lander; T J Hudson
Journal:  Science       Date:  1996-10-25       Impact factor: 47.728

4.  Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2.

Authors:  K Sadhu; S I Reed; H Richardson; P Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

Review 5.  The 5q- abnormality.

Authors:  S D Nimer; D W Golde
Journal:  Blood       Date:  1987-12       Impact factor: 22.113

6.  Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo.

Authors:  B L Samuels; R A Larson; M M Le Beau; K M Daly; M A Bitter; J W Vardiman; C M Barker; J D Rowley; H M Golomb
Journal:  Leukemia       Date:  1988-02       Impact factor: 11.528

7.  Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia.

Authors:  C L Willman; C E Sever; M G Pallavicini; H Harada; N Tanaka; M L Slovak; H Yamamoto; K Harada; T C Meeker; A F List
Journal:  Science       Date:  1993-02-12       Impact factor: 47.728

8.  The Fourth International Workshop on Chromosomes in Leukemia: a prospective study of acute nonlymphocytic leukemia. Chicago, Illinois, U.S.A., September 2-7, 1982.

Authors: 
Journal:  Cancer Genet Cytogenet       Date:  1984-03

9.  Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.

Authors:  M M Le Beau; K S Albain; R A Larson; J W Vardiman; E M Davis; R R Blough; H M Golomb; J D Rowley
Journal:  J Clin Oncol       Date:  1986-03       Impact factor: 44.544

10.  Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases.

Authors:  M M Le Beau; R Espinosa; W L Neuman; W Stock; D Roulston; R A Larson; M Keinanen; C A Westbrook
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

View more
  30 in total

Review 1.  Molecular dissection of the 5q deletion in myelodysplastic syndrome.

Authors:  Benjamin L Ebert
Journal:  Semin Oncol       Date:  2011-10       Impact factor: 4.929

2.  The 5q- syndrome: biology and treatment.

Authors:  Eric Padron; Rami Komrokji; Alan F List
Journal:  Curr Treat Options Oncol       Date:  2011-12

3.  Anlotinib inhibits synovial sarcoma by targeting GINS1: a novel downstream target oncogene in progression of synovial sarcoma.

Authors:  L Tang; W Yu; Y Wang; H Li; Z Shen
Journal:  Clin Transl Oncol       Date:  2019-04-08       Impact factor: 3.405

4.  Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia.

Authors:  Zhijian Qian; Anthony A Fernald; Lucy A Godley; Richard A Larson; Michelle M Le Beau
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-04       Impact factor: 11.205

5.  The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q.

Authors:  A Borkhardt; S Bojesen; O A Haas; U Fuchs; D Bartelheimer; I F Loncarevic; R M Bohle; J Harbott; R Repp; U Jaeger; S Viehmann; T Henn; P Korth; D Scharr; F Lampert
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

Review 6.  Myelodysplastic syndromes.

Authors:  Olatoyosi Odenike; John Anastasi; Michelle M Le Beau
Journal:  Clin Lab Med       Date:  2011-10-10       Impact factor: 1.935

7.  Evolutionary conservation of zebrafish linkage group 14 with frequently deleted regions of human chromosome 5 in myeloid malignancies.

Authors:  Ting Xi Liu; Yi Zhou; John P Kanki; Min Deng; Jennifer Rhodes; Hong Wei Yang; Xiao Ming Sheng; Leonard I Zon; A Thomas Look
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

Review 8.  Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia.

Authors:  Zhijian Qian; John M Joslin; Thelma R Tennant; Shalini C Reshmi; David J Young; Angela Stoddart; Richard A Larson; Michelle M Le Beau
Journal:  Chem Biol Interact       Date:  2009-12-01       Impact factor: 5.192

Review 9.  Therapy-related myeloid leukemia.

Authors:  Lucy A Godley; Richard A Larson
Journal:  Semin Oncol       Date:  2008-08       Impact factor: 4.929

10.  Integrated genomic analysis implicates haploinsufficiency of multiple chromosome 5q31.2 genes in de novo myelodysplastic syndromes pathogenesis.

Authors:  Timothy A Graubert; Michelle A Payton; Jin Shao; Richard A Walgren; Ryan S Monahan; John L Frater; Mark A Walshauser; Mike G Martin; Yumi Kasai; Matthew J Walter
Journal:  PLoS One       Date:  2009-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.